Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

NBSE NeuBase Therapeutics Inc

0,378

0,00 (0,00%)

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
Von Aug 2024 bis Sep 2024

Click Here for more NeuBase Therapeutics Charts.

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
Von Sep 2023 bis Sep 2024

Click Here for more NeuBase Therapeutics Charts.

News NeuBase Therapeutics Inc

Form EFFECT - Notice of Effectiveness
Mittwoch 3 Juli 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Donnerstag 27 Juni 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Donnerstag 27 Juni 2024 (3 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Donnerstag 27 Juni 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 27 Juni 2024 (3 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 3 Juni 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 31 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 22 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Donnerstag 16 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (5 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 6 Mai 2024 (5 Monate vor) • Edgar (US Regulatory)

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
Freitag 5 April 2024 (6 Monate vor) • GlobeNewswire Inc.

Weitere NeuBase Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen